Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
Open Access
- 9 September 2004
- journal article
- research article
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 19 (2) , 111-117
- https://doi.org/10.1038/sj.jhh.1001787
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summaryBMJ, 2004
- Hypertension in people with Type 2 diabetes: knowledge‐based diabetes‐specific guidelinesDiabetic Medicine, 2003
- Treatment for newly diagnosed hypertension: patterns of prescribing and antihypertensive effectiveness in the UKJournal of the Royal Society of Medicine, 2003
- The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertensionJournal Of Hypertension, 2003
- A strategy to reduce cardiovascular disease by more than 80%BMJ, 2003
- Better blood pressure control: how to combine drugsJournal of Human Hypertension, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)Diabetes Care, 1997
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.BMJ, 1991